纵横研报
Ticker Detail

688098.SHG

¥9.39+4.57% 申联生物 Biotechnology
00Reports China 医疗健康
Shanghai Shen Lian Biomedical Corp
医疗健康 · 生物科技

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.

MARKET 市值 3.76B CNY 52W ¥6.09 – ¥17.57 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -20.5% ROE -1.7% 营业利润率 -3.6% 净利润率 -7.1%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制